Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Yin-Suo Zheng"'
Autor:
Huai-Yu Wang, Sha Gong, Guo-Hui Li, Ya-Zhou Yao, Yin-Suo Zheng, Xiao-Hong Lu, Su-Hua Wei, Wei-Wei Qin, Hai-Bo Liu, Meng-Chang Wang, Jie-Ying Xi, Li-Mei Chen, Mei Zhang, Xin-Xin Zhang, Hui-Yun Zhang, Cheng-Sheng Zhang, David N. Wald, Hong-Hu Zhu, Li Liu, Peng-Cheng He
Publikováno v:
Blood Cancer Journal, Vol 12, Iss 11, Pp 1-8 (2022)
Abstract The combination of all-trans retinoic acid (ATRA) and arsenic trioxide (ATO) has been demonstrated to have comparable effectiveness or better to ATRA and chemotherapy (CHT) in non-high-risk acute promyelocytic leukemia (APL). However, the ef
Externí odkaz:
https://doaj.org/article/8ff8843d3692431d8c1052988b524ede
Autor:
Huai-Yu Wang, Sha Gong, Guo-Hui Li, Ya-Zhou Yao, Yin-Suo Zheng, Xiao-Hong Lu, Su-Hua Wei, Wei-Wei Qin, Hai-Bo Liu, Meng-Chang Wang, Jie-Ying Xi, Limei Chen, mei zhang, Xin-Xin Zhang, Hui-Yun Zhang, Cheng-Shang Zhang, David Wald, Hong-Hu Zhu, Li Liu, Peng-Cheng He
The combination of all-trans retinoic acid (ATRA) and arsenic trioxide (ATO) has been demonstrated to be at least equally effective to ATRA and chemotherapy (CHT) in non-high-risk acute promyelocytic leukemia (APL). However, the efficacy of ATRA-ATO
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1b89952c80106e1785dfdb7f2fe6aa9c
https://doi.org/10.21203/rs.3.rs-1649569/v2
https://doi.org/10.21203/rs.3.rs-1649569/v2
Publikováno v:
Biochemical and biophysical research communications. 516(4)
Leukemia remains a fatal disease for most patients and effective therapeutic strategies are urgently required. Typhaneoside (TYP) is a major flavonoid in the extract of Pollen Typhae, showing significant biological and pharmacological effects. In the
Autor:
Zhi, Wang, Jin-Ping, Feng, Miao-Wang, Hao, Yin-Suo, Zheng, Yu-Ping, Tian, Ya-Zhou, Yao, Xiu-Qin, Bai
Publikováno v:
Zhongguo shi yan xue ye xue za zhi. 11(5)
To explore the clinical features, risk factors an d treatment of retinoic acid syndrome (RAS) in patients with acute promyelocytic leukemia (APL) treated with retinoic acid, the clinical and laboratory data of 11 APL patients with RAS were retrospect